- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2017–2022 · research · R01
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers
Jinbo Chen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2023 · cooperative agreement · U24
Cancer Immunologic Data Commons
Ethan Cerami · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2027 · research · R01
Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity
Kimmie Ng · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2018 · fellowship · F32
Decoding PGC-1a1 Control of Energy Metabolism
Daniel Egan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
Kimmie Ng · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Investigating 53BP1 'dephosphorylation' as a critical determinant of PARP
Dipanjan Chowdhury · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · program · P01
Human Cancer Suppressor Functions of Protein Phosphatase 2A
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017 · career development · K99
Creatine metabolism in obesity and diabetes
Lawrence Kazak · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
MYB family alterations in pediatric gliomas
Rameen Beroukhim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
Kimberly Stegmaier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · research · R21
Reducing viral reservoirs by opening HIV-1 Env to antibody attack
Joseph G Sodroski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R50
Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases
Eunyoung Park · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · career development · K99
Inflammation, Physical Activity, and Colon Cancer Recurrence and Survival
Justin C Brown · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2024 · research · R25
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2018 · research · R01
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
Kimberly Stegmaier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2018 · fellowship · F32
Bromodomain Inhibitors Correct Bioenergetic Deficiency Caused by Mitochondrial Disease Complex Mutations
Joeva J. Barrow · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R25
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2024 · research · R01
Prevention of HIV-1 transmission by small-molecule CD4-mimetic entry inhibitors
Navid Madani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · program · P01
Human Cancer Suppressor Functions of Protein Phosphatase 2A
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2028 · cooperative agreement · U24
Cancer Immune Monitoring and Analysis Center
Frank S Hodi · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
PediQUEST: Improving Children's Quality of Life through e-PROMS and Palliative Care
Joanne Wolfe · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · award
Developing Precision Therapies for Lung Cancer
Pasi Janne · Dana-Farber Cancer Institute · funded by American Cancer Society
2017–2021 · research · R01
A systems biology approach for dissecting enhancer hierarchy
Guo-Cheng Yuan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
PediQUEST: Improving Children's Quality of Life through e-PROMS and Palliative Care
Joanne Wolfe · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
Andrew James Aguirre · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2023 · cooperative agreement · U24
Cancer Immune Monitoring and Analysis Center
Frank S Hodi · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R33
Reducing viral reservoirs by opening HIV-1 Env to antibody attack
Joseph G Sodroski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Metabolic and Bioenergetic Control in Mitochondrial Diseases
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
MYB family alterations in pediatric gliomas
Rameen Beroukhim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
Kimmie Ng · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · research · R01
GENOMIC INSIGHTS AND THERAPEUTIC TARGETING OF ORAL CANCER TUMOR INITIATING CELLS
Ravindra Uppaluri · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · career development · K99
The PI3K/AKT Pathway Regulates Histone H3 Modification
Jennifer Marie Spangle · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2024 · research · R25
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia
Mark A. Murakami · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2018 · research · R56
Elucidating protective CTL immunity through physical detection of epitopes in conjunction with assessment of TCR-pMHC bond lifetimes under load
Ellis L Reinherz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
MYB family alterations in pediatric gliomas
Rameen Beroukhim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · grant · PRCRP
Immunotherapy of Melanoma: Targeting Helios in the Tumor Microenvironment for Effector Cell Conversion
Harvey Cantor · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2017 · fellowship · AACR Basic Cancer Research Fellowship
Characterization of endocrine resistance mechanisms in ER+ breast cancer
Pingping Mao · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
2017 · research · AACR-Bayer Innovation and Discovery Grants
DCLK1 kinase inhibition as a targeted therapy for K-Ras mutant pancreatic cancer
Nathanael S. Gray · Dana-Farber Cancer Institute · funded by American Association for Cancer Research
2017 · career development · Young Investigator Award
Using the sarcoma enhancer landscape to identify sarcoma-specific vulnerabilities.
Matthew Hemming · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
